Advertisement
Screener

OTC:ECOC | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ABVC BIOPHARMA, INC.

1.0 / 5 stars · 24/120 Roast Me

ABVC BIOPHARMA, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

Financial Statements › Income Statement › Net Income

us-gaap:ProfitLoss · last filed 2026-08-12

  • ABVC BIOPHARMA, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$810.48K.
  • ABVC BIOPHARMA, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$1.69M.
  • ABVC BIOPHARMA, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$3.02M.
  • ABVC BIOPHARMA, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$2.08M.
  • ABVC BIOPHARMA, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$8.38M.
  • ABVC BIOPHARMA, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$5.26M.
  • ABVC BIOPHARMA, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$8.28M.
  • ABVC BIOPHARMA, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$16.31M.
Period endNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filedNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filedNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month as first filedNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed
2026-06-30-$810.48K
10-Q · filed 2026-08-12
-$2.50M
10-Q · filed 2026-08-12
-$5.52M
derived: sum of 3 quarters · filed 2026-08-12
-$7.60M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$1.69M
10-Q · filed 2026-05-18
-$4.71M
derived: sum of 2 quarters · filed 2026-05-18
-$6.79M
derived: sum of 3 quarters · filed 2026-05-18
-$9.12M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31-$3.02M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03
-$5.10M
derived: sum of 2 quarters · filed 2026-03-03
-$7.43M
derived: sum of 3 quarters · filed 2026-08-12
-$8.38M
10-K · filed 2026-03-03
2025-09-30-$2.08M
10-Q/A · filed 2026-03-03
-$1.29M
10-Q · filed 2025-11-03
-$4.42M
derived: sum of 2 quarters · filed 2026-08-12
-$5.36M
10-Q/A · filed 2026-03-03
-$4.56M
10-Q · filed 2025-11-03
-$6.16M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30-$2.33M
10-Q · filed 2026-08-12
-$3.28M
10-Q · filed 2026-08-12
-$4.07M
derived: sum of 3 quarters · filed 2026-08-12
-$4.56M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$944.19K
10-Q · filed 2026-05-18
-$1.74M
derived: sum of 2 quarters · filed 2026-05-18
-$2.23M
derived: sum of 3 quarters · filed 2026-05-18
-$3.28M
derived: sum of 4 quarters · filed 2026-05-18
2024-12-31-$796.53K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03
-$1.28M
derived: sum of 2 quarters · filed 2026-03-03
-$2.33M
derived: sum of 3 quarters · filed 2026-03-03
-$5.26M
10-K · filed 2026-03-03
2024-09-30-$487.43K
10-Q/A · filed 2026-03-03
-$134.27K
10-Q · filed 2024-11-14
-$1.53M
derived: sum of 2 quarters · filed 2026-03-03
-$4.46M
10-Q/A · filed 2026-03-03
-$5.39M
10-Q · filed 2024-11-14
-$5.16M
derived: sum of 4 quarters · filed 2026-03-03
2024-06-30-$1.05M
10-Q · filed 2025-08-13
-$1.27M
10-Q · filed 2024-08-14
-$3.98M
10-Q · filed 2025-08-13
-$5.25M
10-Q · filed 2024-08-14
-$4.68M
derived: sum of 3 quarters · filed 2025-08-13
-$8.04M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31-$2.93M
10-Q · filed 2025-04-30
-$3.98M
10-Q · filed 2024-05-17
-$3.63M
derived: sum of 2 quarters · filed 2025-04-30
-$7.00M
derived: sum of 3 quarters · filed 2025-04-30
-$9.31M
derived: sum of 4 quarters · filed 2025-04-30
2023-12-31-$700.31K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
-$4.07M
derived: sum of 2 quarters · filed 2025-04-15
-$6.38M
derived: sum of 3 quarters · filed 2025-04-15
-$8.28M
10-K · filed 2025-04-15
-$10.91M
10-K · filed 2024-03-13
2023-09-30-$3.37M
10-Q · filed 2024-11-14
-$5.68M
derived: sum of 2 quarters · filed 2024-11-14
-$7.58M
10-Q · filed 2024-11-14
-$12.08M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$2.32M
10-Q · filed 2024-08-14
-$4.21M
10-Q · filed 2024-11-14
-$8.71M
derived: sum of 3 quarters · filed 2024-08-14
-$12.49M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$1.90M
10-Q · filed 2024-05-17
-$6.40M
derived: sum of 2 quarters · filed 2024-05-17
-$10.17M
derived: sum of 3 quarters · filed 2024-05-17
-$12.12M
derived: sum of 4 quarters · filed 2024-05-17
2022-12-31-$4.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13
-$8.28M
derived: sum of 2 quarters · filed 2024-03-13
-$10.22M
derived: sum of 3 quarters · filed 2024-03-13
-$16.31M
10-K · filed 2024-03-13
2022-09-30-$3.78M
10-Q · filed 2023-11-15
-$5.72M
derived: sum of 2 quarters · filed 2023-11-15
-$11.81M
10-Q · filed 2023-11-15
-$18.71M
derived: sum of 4 quarters · filed 2023-11-15
2022-06-30-$1.95M
10-Q · filed 2023-08-14
-$8.03M
10-Q · filed 2023-11-15
-$14.94M
derived: sum of 3 quarters · filed 2023-08-14
-$16.82M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$6.09M
10-Q · filed 2023-05-15
-$12.99M
derived: sum of 2 quarters · filed 2023-05-15
-$14.88M
derived: sum of 3 quarters · filed 2023-05-15
-$16.93M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$6.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$8.79M
derived: sum of 2 quarters · filed 2023-03-31
-$10.84M
derived: sum of 3 quarters · filed 2023-03-31
-$12.04M
10-K · filed 2023-03-31
2021-09-30-$1.89M
10-Q · filed 2022-11-14
-$3.94M
derived: sum of 2 quarters · filed 2022-11-14
-$5.13M
10-Q · filed 2022-11-14
-$10.10M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$2.05M
10-Q · filed 2022-11-14
-$3.25M
10-Q · filed 2022-08-15
-$8.22M
derived: sum of 3 quarters · filed 2022-11-14
-$10.35M
derived: sum of 4 quarters · filed 2022-11-14
2021-03-31-$1.20M
10-Q · filed 2022-11-14
-$6.16M
derived: sum of 2 quarters · filed 2022-11-14
-$8.30M
derived: sum of 3 quarters · filed 2022-11-14
-$10.48M
derived: sum of 4 quarters · filed 2022-11-14
2020-12-31-$4.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
-$7.10M
derived: sum of 2 quarters · filed 2022-03-31
-$9.28M
derived: sum of 3 quarters · filed 2022-03-31
-$10.59M
10-K · filed 2022-03-31
2020-09-30-$2.13M
10-Q · filed 2021-11-15
-$4.32M
derived: sum of 2 quarters · filed 2021-11-15
-$5.62M
10-Q · filed 2021-11-15
2020-06-30-$2.18M
10-Q · filed 2021-08-12
-$3.49M
derived: sum of 2 quarters · filed 2021-08-12
2020-03-31-$1.31M
10-Q · filed 2021-08-12
2019-12-31-$3.93M
10-K · filed 2020-05-15
2019-09-30-$1.33M
10-Q · filed 2019-11-18
-$1.94M
derived: sum of 2 quarters · filed 2020-08-14
-$2.82M
derived: sum of 3 quarters · filed 2020-08-14
2019-06-30-$614.45K
10-Q · filed 2020-08-14
-$1.49M
derived: sum of 2 quarters · filed 2020-08-14
2019-03-31-$873.32K
10-Q · filed 2020-08-14
2018-12-31-$6.06M
10-K · filed 2020-05-15
2018-09-30-$687.30K
10-Q · filed 2019-11-18
-$1.42M
derived: sum of 2 quarters · filed 2019-11-18
-$2.14M
derived: sum of 3 quarters · filed 2019-11-18
2018-06-30-$736.04K
10-Q · filed 2019-11-18
-$1.45M
derived: sum of 2 quarters · filed 2019-11-18
2018-03-31-$713.62K
10-Q · filed 2019-11-18